UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in chronic diarrhoea and how to avoid them

Julian Roger Ford Walters

Summary

AI Generated

Chronic diarrhoea, defined as lasting more than 3 or 4 weeks, is a common condition affecting an estimated 5% of the population who seek medical advice, with many patients receiving diagnoses of IBS-D or functional diarrhoea after exclusion of serious conditions.

  • Most people presenting with chronic diarrhoea will not have inflammatory bowel disease or colorectal cancer.
  • If less common disorders are not considered, patients may be given a diagnosis of diarrhoea-predominant irritable bowel syndrome (IBS-D) or functional diarrhoea.
  • Many different treatments are used for IBS-D but often benefit only a small proportion of patients, leaving many with unmet needs seeking further investigation, advice and treatment.
  • Gastroenterologists commonly encounter patients whose principal complaint is frequent, loose stools requiring investigation to exclude serious conditions.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lacy BE, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393–1407.e5. [Link]
2.
Arasaradnam RP, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380–1399. [Link]
3.
Stotzer PO, et al. Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J 2015; 3: 381–386. [Link]
4.
Fuchs V, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol 2014; 49: 1304–1310. [Link]
5.
Bannaga A, et al. How bad is bile acid diarrhoea: an online survey of patient–reported symptoms and outcomes. BMJ Open Gastroenterol 2017; 4: e000116. [Link]
6.
Valentin N, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta–analysis. Gut 2016; 65: 1951–1959. [Link]
7.
Guagnozzi D, et al. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Aliment Pharmacol Ther 2016; 43: 851–862. [Link]
8.
Patel SG and Ahnen DJ. Colorectal cancer in the Young. Curr Gastroenterol Rep 2018; 20: 15. [Link]
9.
Wedlake L, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009; 30: 707–717. [Link]
10.
Turner JM, et al. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017; 8: 279–283. [Link]
11.
Fernandes DCR, et al. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea? Frontline Gastroenterology 2019; 10: 72–76. [Link]
12.
Vijayvargiya P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 2017; 46: 581–588. [Link]
13.
Vijayvargiya P, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol Epub ahead of print 11 June 2018. DOI: 10.1016/j.cgh.2018.05.050. [Link]
14.
Pardi DS, et al. American Gastroenterological Association Institute technical review on the medical management of microscopic colitis. Gastroenterology 2016; 150: 247–274. [Link]
15.
Rangan V, et al. Risk factors for fecal urgency among individuals with and without diarrhea, based on data from the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2018; 16: 1450–1458. [Link]
16.
Carrington EV, et al. Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol 2018; 15: 309–323. [Link]
17.
Staudacher HM and Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017; 66: 1517–1527. [Link]
18.
De Georgio R, et al. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016; 65: 169–178. [Link]
19.
Watson L, et al. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome? Clin Med (Lond) 2015; 15: 536–540. [Link]
20.
Munch A, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 2016; 65: 47–56. [Link]

Abstract

Chronic diarrhoea, lasting more than 3 or 4 weeks, is a common condition with a wide variety of different possible causes. Estimates suggest 5% of the population have experienced chronic diarrhoea and sought medical advice about it. All gastroenterologists see many patients whose principal complaint is frequent, loose stools, and will be aware of investigations that are needed to diagnose serious conditions such as inflammatory bowel disease (IBD) or colorectal cancer (CRC). Most people who present with chronic diarrhoea will not have these conditions and, if less common disorders are not considered, may be given a diagnosis of diarrhoea-predominant irritable bowel syndrome (IBS-D) or perhaps functional diarrhoea. Many different treatments are used for IBS-D and often benefit only a small proportion of patients, leaving many with unmet needs, seeking further investigation, advice and treatment.

Topics

Neurogastroenterology & Motility

Citation

Walters JRF. Mistakes in chronic diarrhoea and how to avoid them. UEG Education 2019; 19: 1–4.

Published

2019

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Mistakes in hepatitis C and how to avoid them

Mistakes in hepatitis C and how to avoid them

Gonçalo Alexandrino Gonçalo Alexandrino, Ana Catarina Garcia

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in jejunal feeding and how to avoid them

Mistakes in jejunal feeding and how to avoid them

Ashley Bond Ashley Bond, Simon Lal

Mistakes in transitional care for children and young adults and how to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend, Philip Newsome

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lacy BE, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393–1407.e5. [Link]
2.
Arasaradnam RP, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380–1399. [Link]
3.
Stotzer PO, et al. Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J 2015; 3: 381–386. [Link]
4.
Fuchs V, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol 2014; 49: 1304–1310. [Link]
5.
Bannaga A, et al. How bad is bile acid diarrhoea: an online survey of patient–reported symptoms and outcomes. BMJ Open Gastroenterol 2017; 4: e000116. [Link]
6.
Valentin N, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta–analysis. Gut 2016; 65: 1951–1959. [Link]
7.
Guagnozzi D, et al. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Aliment Pharmacol Ther 2016; 43: 851–862. [Link]
8.
Patel SG and Ahnen DJ. Colorectal cancer in the Young. Curr Gastroenterol Rep 2018; 20: 15. [Link]
9.
Wedlake L, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009; 30: 707–717. [Link]
10.
Turner JM, et al. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017; 8: 279–283. [Link]
11.
Fernandes DCR, et al. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea? Frontline Gastroenterology 2019; 10: 72–76. [Link]
12.
Vijayvargiya P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 2017; 46: 581–588. [Link]
13.
Vijayvargiya P, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol Epub ahead of print 11 June 2018. DOI: 10.1016/j.cgh.2018.05.050. [Link]
14.
Pardi DS, et al. American Gastroenterological Association Institute technical review on the medical management of microscopic colitis. Gastroenterology 2016; 150: 247–274. [Link]
15.
Rangan V, et al. Risk factors for fecal urgency among individuals with and without diarrhea, based on data from the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2018; 16: 1450–1458. [Link]
16.
Carrington EV, et al. Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol 2018; 15: 309–323. [Link]
17.
Staudacher HM and Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017; 66: 1517–1527. [Link]
18.
De Georgio R, et al. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016; 65: 169–178. [Link]
19.
Watson L, et al. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome? Clin Med (Lond) 2015; 15: 536–540. [Link]
20.
Munch A, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 2016; 65: 47–56. [Link]

Abstract

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a subclassification of steatotic liver disease (SLD), defined as the presence of excess triglyceride storage in the liver in conjunction with at least one cardiometabolic risk factor and no other discernible cause.1 Cirrhosis secondary to MASH is the most common cause of liver disease in the world and is the fastest-growing indication for liver transplantation, but it also has a >50% recurrence rate post-transplantation.

Topics

Hepatobiliary

Citation

Townsend SA and Newsome PN. Mistakes in nonalcoholic fatty liver disease and how to avoid them. UEG Education 2017; 17: 39–41.

Published

2024

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Mistakes in hepatitis C and how to avoid them

Mistakes in hepatitis C and how to avoid them

Gonçalo Alexandrino Gonçalo Alexandrino, Ana Catarina Garcia

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in jejunal feeding and how to avoid them

Mistakes in jejunal feeding and how to avoid them

Ashley Bond Ashley Bond, Simon Lal

Mistakes in transitional care for children and young adults and how to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in hepatitis C and how to avoid them

Ana Catarina Garcia, Gonçalo Alexandrino

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lacy BE, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393–1407.e5. [Link]
2.
Arasaradnam RP, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380–1399. [Link]
3.
Stotzer PO, et al. Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J 2015; 3: 381–386. [Link]
4.
Fuchs V, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol 2014; 49: 1304–1310. [Link]
5.
Bannaga A, et al. How bad is bile acid diarrhoea: an online survey of patient–reported symptoms and outcomes. BMJ Open Gastroenterol 2017; 4: e000116. [Link]
6.
Valentin N, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta–analysis. Gut 2016; 65: 1951–1959. [Link]
7.
Guagnozzi D, et al. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Aliment Pharmacol Ther 2016; 43: 851–862. [Link]
8.
Patel SG and Ahnen DJ. Colorectal cancer in the Young. Curr Gastroenterol Rep 2018; 20: 15. [Link]
9.
Wedlake L, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009; 30: 707–717. [Link]
10.
Turner JM, et al. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017; 8: 279–283. [Link]
11.
Fernandes DCR, et al. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea? Frontline Gastroenterology 2019; 10: 72–76. [Link]
12.
Vijayvargiya P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 2017; 46: 581–588. [Link]
13.
Vijayvargiya P, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol Epub ahead of print 11 June 2018. DOI: 10.1016/j.cgh.2018.05.050. [Link]
14.
Pardi DS, et al. American Gastroenterological Association Institute technical review on the medical management of microscopic colitis. Gastroenterology 2016; 150: 247–274. [Link]
15.
Rangan V, et al. Risk factors for fecal urgency among individuals with and without diarrhea, based on data from the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2018; 16: 1450–1458. [Link]
16.
Carrington EV, et al. Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol 2018; 15: 309–323. [Link]
17.
Staudacher HM and Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017; 66: 1517–1527. [Link]
18.
De Georgio R, et al. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016; 65: 169–178. [Link]
19.
Watson L, et al. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome? Clin Med (Lond) 2015; 15: 536–540. [Link]
20.
Munch A, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 2016; 65: 47–56. [Link]

Abstract

Hepatitis C virus (HCV) infection remains an important global health concern. It is estimated that there are approximately 50 million people infected with HCV globally, with around 1 million new infections each year and about 242,000 deaths annually attributed to HCV-related complications. Most acute HCV infections (55–85%) become chronic due to the virus’s effective evasion strategies, with spontaneous clearance being rare once chronicity is established. This condition often progresses silently, with many individuals unaware of their infection until advanced liver damage has occurred. If left untreated, HCV can lead to severe complications, including liver cirrhosis and hepatocellular carcinoma (HCC). HCV transmission occurs mainly through percutaneous exposure to infected blood. HCV can also spread from mother to infant (vertical transmission) and, less frequently, via sexual contact.1,2 In recent years, the introduction of oral direct-acting antivirals (DAAs), with remarkable safety and effectiveness profiles, has led to a sustained virological response (SVR) in virtually all (>97%) HCV-infected patients, regardless of HCV genotype or disease stage. However, significant barriers remain, such as issues with diagnosis, access to treatment and awareness of the disease.

Here, we discuss some of the misconceptions in HCV management and provide a practical management approach grounded in evidence and clinical experience.

Topics

Hepatobiliary

Citation

Garcia A.C and Alexandrino G. Mistakes in hepatits C and how to avoid them. UEG Education 2025; 25: 14-17.

Published

2025

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Mistakes in hepatitis C and how to avoid them

Mistakes in hepatitis C and how to avoid them

Gonçalo Alexandrino Gonçalo Alexandrino, Ana Catarina Garcia

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in jejunal feeding and how to avoid them

Mistakes in jejunal feeding and how to avoid them

Ashley Bond Ashley Bond, Simon Lal

Mistakes in transitional care for children and young adults and how to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord, Roos E. Pouw

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lacy BE, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393–1407.e5. [Link]
2.
Arasaradnam RP, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380–1399. [Link]
3.
Stotzer PO, et al. Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J 2015; 3: 381–386. [Link]
4.
Fuchs V, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol 2014; 49: 1304–1310. [Link]
5.
Bannaga A, et al. How bad is bile acid diarrhoea: an online survey of patient–reported symptoms and outcomes. BMJ Open Gastroenterol 2017; 4: e000116. [Link]
6.
Valentin N, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta–analysis. Gut 2016; 65: 1951–1959. [Link]
7.
Guagnozzi D, et al. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Aliment Pharmacol Ther 2016; 43: 851–862. [Link]
8.
Patel SG and Ahnen DJ. Colorectal cancer in the Young. Curr Gastroenterol Rep 2018; 20: 15. [Link]
9.
Wedlake L, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009; 30: 707–717. [Link]
10.
Turner JM, et al. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017; 8: 279–283. [Link]
11.
Fernandes DCR, et al. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea? Frontline Gastroenterology 2019; 10: 72–76. [Link]
12.
Vijayvargiya P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 2017; 46: 581–588. [Link]
13.
Vijayvargiya P, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol Epub ahead of print 11 June 2018. DOI: 10.1016/j.cgh.2018.05.050. [Link]
14.
Pardi DS, et al. American Gastroenterological Association Institute technical review on the medical management of microscopic colitis. Gastroenterology 2016; 150: 247–274. [Link]
15.
Rangan V, et al. Risk factors for fecal urgency among individuals with and without diarrhea, based on data from the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2018; 16: 1450–1458. [Link]
16.
Carrington EV, et al. Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol 2018; 15: 309–323. [Link]
17.
Staudacher HM and Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017; 66: 1517–1527. [Link]
18.
De Georgio R, et al. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016; 65: 169–178. [Link]
19.
Watson L, et al. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome? Clin Med (Lond) 2015; 15: 536–540. [Link]
20.
Munch A, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 2016; 65: 47–56. [Link]

Abstract

Proton pump inhibitors (PPIs), first introduced with omeprazole in 1988, revolutionized the treatment of gastric acid-related conditions like gastro-oesophageal reflux disease, gastroduodenal ulcers, and Helicobacter pylori infections. Despite their effectiveness, PPIs are often prescribed for conditions without a proven link to gastric acid, such as dyspepsia and upper abdominal discomfort. Long-term use of PPIs has raised safety concerns, including risks of vitamin and mineral malabsorption, pneumonia, gastrointestinal infections, and dementia. This Mistakes In article addresses nine common mistakes in PPI use and aims to clarify misconceptions about their use.

Topics

Digestive Oncology Oesophagus

Citation

Pouw R.E. and Bredenoord A.J. Mistakes in the use of PPIs and how to avoid them. UEG Education 2017; 17: 15–17.

Published

2024

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Mistakes in hepatitis C and how to avoid them

Mistakes in hepatitis C and how to avoid them

Gonçalo Alexandrino Gonçalo Alexandrino, Ana Catarina Garcia

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in jejunal feeding and how to avoid them

Mistakes in jejunal feeding and how to avoid them

Ashley Bond Ashley Bond, Simon Lal

Mistakes in transitional care for children and young adults and how to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in jejunal feeding and how to avoid them

Ashley Bond, Simon Lal

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lacy BE, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393–1407.e5. [Link]
2.
Arasaradnam RP, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380–1399. [Link]
3.
Stotzer PO, et al. Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J 2015; 3: 381–386. [Link]
4.
Fuchs V, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol 2014; 49: 1304–1310. [Link]
5.
Bannaga A, et al. How bad is bile acid diarrhoea: an online survey of patient–reported symptoms and outcomes. BMJ Open Gastroenterol 2017; 4: e000116. [Link]
6.
Valentin N, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta–analysis. Gut 2016; 65: 1951–1959. [Link]
7.
Guagnozzi D, et al. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Aliment Pharmacol Ther 2016; 43: 851–862. [Link]
8.
Patel SG and Ahnen DJ. Colorectal cancer in the Young. Curr Gastroenterol Rep 2018; 20: 15. [Link]
9.
Wedlake L, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009; 30: 707–717. [Link]
10.
Turner JM, et al. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017; 8: 279–283. [Link]
11.
Fernandes DCR, et al. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea? Frontline Gastroenterology 2019; 10: 72–76. [Link]
12.
Vijayvargiya P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 2017; 46: 581–588. [Link]
13.
Vijayvargiya P, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol Epub ahead of print 11 June 2018. DOI: 10.1016/j.cgh.2018.05.050. [Link]
14.
Pardi DS, et al. American Gastroenterological Association Institute technical review on the medical management of microscopic colitis. Gastroenterology 2016; 150: 247–274. [Link]
15.
Rangan V, et al. Risk factors for fecal urgency among individuals with and without diarrhea, based on data from the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2018; 16: 1450–1458. [Link]
16.
Carrington EV, et al. Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol 2018; 15: 309–323. [Link]
17.
Staudacher HM and Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017; 66: 1517–1527. [Link]
18.
De Georgio R, et al. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016; 65: 169–178. [Link]
19.
Watson L, et al. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome? Clin Med (Lond) 2015; 15: 536–540. [Link]
20.
Munch A, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 2016; 65: 47–56. [Link]

Abstract

Topics

Small Intestine & Nutrition

Citation

Bond A and Lal S. Mistakes in jejunal feeding and how to avoid them. UEG Education 2020; 20: 17–19. 

Published

2020

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Mistakes in hepatitis C and how to avoid them

Mistakes in hepatitis C and how to avoid them

Gonçalo Alexandrino Gonçalo Alexandrino, Ana Catarina Garcia

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in jejunal feeding and how to avoid them

Mistakes in jejunal feeding and how to avoid them

Ashley Bond Ashley Bond, Simon Lal

Mistakes in transitional care for children and young adults and how to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra, Hans Törnblom, Jorge Amil Dias, Moriam Mustapha

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lacy BE, et al. Bowel Disorders. Gastroenterology 2016; 150: 1393–1407.e5. [Link]
2.
Arasaradnam RP, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut 2018; 67: 1380–1399. [Link]
3.
Stotzer PO, et al. Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J 2015; 3: 381–386. [Link]
4.
Fuchs V, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol 2014; 49: 1304–1310. [Link]
5.
Bannaga A, et al. How bad is bile acid diarrhoea: an online survey of patient–reported symptoms and outcomes. BMJ Open Gastroenterol 2017; 4: e000116. [Link]
6.
Valentin N, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta–analysis. Gut 2016; 65: 1951–1959. [Link]
7.
Guagnozzi D, et al. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Aliment Pharmacol Ther 2016; 43: 851–862. [Link]
8.
Patel SG and Ahnen DJ. Colorectal cancer in the Young. Curr Gastroenterol Rep 2018; 20: 15. [Link]
9.
Wedlake L, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009; 30: 707–717. [Link]
10.
Turner JM, et al. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017; 8: 279–283. [Link]
11.
Fernandes DCR, et al. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea? Frontline Gastroenterology 2019; 10: 72–76. [Link]
12.
Vijayvargiya P, et al. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 2017; 46: 581–588. [Link]
13.
Vijayvargiya P, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol Epub ahead of print 11 June 2018. DOI: 10.1016/j.cgh.2018.05.050. [Link]
14.
Pardi DS, et al. American Gastroenterological Association Institute technical review on the medical management of microscopic colitis. Gastroenterology 2016; 150: 247–274. [Link]
15.
Rangan V, et al. Risk factors for fecal urgency among individuals with and without diarrhea, based on data from the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol 2018; 16: 1450–1458. [Link]
16.
Carrington EV, et al. Expert consensus document: Advances in the evaluation of anorectal function. Nat Rev Gastroenterol Hepatol 2018; 15: 309–323. [Link]
17.
Staudacher HM and Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017; 66: 1517–1527. [Link]
18.
De Georgio R, et al. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016; 65: 169–178. [Link]
19.
Watson L, et al. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome? Clin Med (Lond) 2015; 15: 536–540. [Link]
20.
Munch A, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 2016; 65: 47–56. [Link]

Abstract

Children and adolescents with chronic diseases requiring lifelong care face unique challenges that affect their daily lives and those of their families. Initially, these patients receive specialized care in pediatric facilities, where parents play a key role in treatment decisions. However, transitioning to adult healthcare facilities is inevitable, and this process, recognized as crucial years ago, involves moving adolescents with chronic conditions from child-centered to adult-oriented care. This transition can be complicated by varying age limits for pediatric care and the scarcity of adult care centers with specific expertise. The transition often requires cooperation between different centers or even countries due to patient mobility. The transition phase is critical, as it can lead to loss of follow-up, treatment suspension, and increased risks of complications or disease relapse. Beyond medical management, various factors influence the long-term prognosis of chronic conditions, making a well-organized transition program essential. While many hospitals have implemented transition models with mixed results in satisfaction, disease control, and follow-up adherence, there are frequent shortcomings in the process. This Mistakes In article will outline eight common mistakes made during the transition from pediatric to adult care, supported by literature and professional experience.

Topics

Primary Care

Citation

Jorge Amil-Dias, Hans Törnblom, Moriam Mustapha and Patrizia Burra. Mistakes in transitional care for children and young adults and how to avoid them. UEG Education 2023; 23: 22-25.

Published

2023

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Mistakes in hepatitis C and how to avoid them

Mistakes in hepatitis C and how to avoid them

Gonçalo Alexandrino Gonçalo Alexandrino, Ana Catarina Garcia

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in jejunal feeding and how to avoid them

Mistakes in jejunal feeding and how to avoid them

Ashley Bond Ashley Bond, Simon Lal

Mistakes in transitional care for children and young adults and how to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

UEG Standards and Guidelines
Consensus
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline

ABSTRACT

Introduction

Chronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non-gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well-structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut-brain interaction disorders should be assessed. United European Gastroenterology (UEG) and the European Society for Neurogastroenterology and Motility (ESNM) identified the need for an updated, evidence-based clinical guideline for the management of chronic nausea and vomiting.

Methods

A multidisciplinary team of experts in the field, including European specialists and national societies, participated in the development of the guideline. Relevant questions were addressed through a literature review and statements were developed and voted on according to a Delphi process.

Results

Ninety-eight statements were identified and voted following the Delphi process. Overall agreement was high, although the grade of scientific evidence was low in many areas. Disagreement was more evident for some pharmacological treatment options. A diagnostic algorithm was developed, focussing on the differentiating features between gastrointestinal motility and gut-brain interaction disorders with predominant nausea and vomiting.

Conclusion

These guidelines provide an evidence-based framework for the evaluation and treatment of patients with chronic nausea and vomiting.

Publisher

European Society of Neurogastroenterology and Motility logo
European Society of Neurogastroenterology and Motility

Guideline

Consensus

Topics

Neurogastroenterology & Motility Paediatrics Primary Care Stomach & H. Pylori

Citation

United European Gastroenterol J.

Published

2025

More Like This:

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Mistakes in metabolic dysfunction associated steatotic liver disease and how to avoid them

Sarah Townsend Sarah Townsend, Philip Newsome

Mistakes in hepatitis C and how to avoid them

Mistakes in hepatitis C and how to avoid them

Gonçalo Alexandrino Gonçalo Alexandrino, Ana Catarina Garcia

Mistakes in the use of PPIs and how to avoid them

Mistakes in the use of PPIs and how to avoid them

Albert J. Bredenoord Albert J. Bredenoord, Roos E. Pouw

Mistakes in jejunal feeding and how to avoid them

Mistakes in jejunal feeding and how to avoid them

Ashley Bond Ashley Bond, Simon Lal

Mistakes in transitional care for children and young adults and how to avoid them

Mistakes in transitional care for children and young adults and how to avoid them

Patrizia Burra Patrizia Burra, Moriam Mustapha, Hans Törnblom, Jorge Amil Dias

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

European Guideline on Chronic Nausea and Vomiting—A UEG and ESNM Consensus for Clinical Management

Carolina Malagelada Carolina Malagelada

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.